Therefore, our study elaborated on a vicious circle in which HCC cells recruit and activate CAFs through αvβ3 integrin/FAK/Akt signaling by secreting Egfl7, and Egfl7-activated CAFs could in turn promote HCC progression. The gene discussed is PTK2; the disease is hepatocellular carcinoma.